Also, 3 brothers with atypical juvenile-onset DTDS have been described for which the predicted DAT activity was approximately 8% (14, 16), strongly supporting a phenotypic spectrum determined by residual uptake activity of DAT. This evidence concerns the gene SLC6A3 and SLC6A3-related dopamine transporter deficiency syndrome.